KYMERA THERAPEUTICS, INC. (KYMR) Operating income 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) annual operating income history from SEC filings — each fiscal year as reported.
-$349.4MFY2025 · since FY2019: -$42.2M → -$349.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$349.4M | -33.5% |
| FY2024 | -$261.6M | -58.1% |
| FY2023 | -$165.5M | -2.7% |
| FY2022 | -$161.3M | -60.4% |
| FY2021 | -$100.5M | -117.1% |
| FY2020 | -$46.3M | -9.7% |
| FY2019 | -$42.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYMR financial trends
KYMR RevenueKYMR Net incomeKYMR Net marginKYMR Gross profitKYMR Gross marginKYMR Operating marginKYMR Operating cash flowKYMR Free cash flowKYMR Capital expendituresKYMR Return on equityKYMR Stock buybacksKYMR Dividends paidKYMR Total assetsKYMR Total liabilitiesKYMR Shareholders’ equityKYMR overview →